Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 28;8(11):e022012.
doi: 10.1136/bmjopen-2018-022012.

Effectiveness of online interventions in preventing depression: a protocol for systematic review and meta-analysis of randomised controlled trials

Alina Rigabert  1 , Emma Motrico  1   2 , Patricia Moreno-Peral  2   3   4 , Davinia M Resurrección  1 , Sonia Conejo-Cerón  2   3   4 , Desirée Navas-Campaña  2   3   4 , Juan Á Bellón  2   3   4   5   6
Affiliations

Effectiveness of online interventions in preventing depression: a protocol for systematic review and meta-analysis of randomised controlled trials

Alina Rigabert et al. BMJ Open. .

Abstract

Introduction: Although evidence exists for the efficacy of psychosocial interventions in preventing depression, little is known about its prevention through online interventions. The objective of this study is to conduct a systematic review and meta-analysis of randomised controlled trials assessing the effectiveness of online interventions in preventing depression in heterogeneous populations.

Methods and analysis: We will conduct a systematic review and meta-analysis of randomised controlled trials that will be identified through searches of PubMed, PsycINFO, WOS, Scopus, OpenGrey, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov and Australia New Zealand Clinical Trials Register . We will also search the reference lists provided in relevant studies and reviews. Experts in the field will be contacted to obtain more references. Two independent reviewers will assess the eligibility criteria of all articles, extract data and determine their risk of bias (Cochrane Collaboration Tool). Baseline depression will be required to have been discarded through standardised interviews or validated self-reports with standard cut-off points. The outcomes will be the incidence of new cases of depression and/or the reduction of depressive symptoms as measured by validated instruments. Pooled standardised mean differences will be calculated using random-effect models. Heterogeneity and publication bias will be estimated. Predefined sensitivity and subgroup analyses will be performed. If heterogeneity is relevant, random-effect meta-regression will be performed.

Ethics and dissemination: The results will be disseminated through peer-reviewed publication and will be presented at a professional conference. Ethical assessment is not required as we will search and assess existing sources of literature.

Trial registration number: CRD42014014804; Results.

Keywords: meta-analysis; online; prevention; randomized controlled trial; systematic review.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

See all similar articles

References

    1. Parker G, McCraw S, Hadzi-Pavlovic D, et al. . Costs of the principal mood disorders: a study of comparative direct and indirect costs incurred by those with bipolar I, bipolar II and unipolar disorders. J Affect Disord 2013;149:46–55. 10.1016/j.jad.2012.10.002 - DOI - PubMed
    1. World Health Organization. Depression and other common mental disorders global health estimates. Geneva, 2017.
    1. GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990 – 2015 : a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2015;2016:1603–58. - PMC - PubMed
    1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442–30. 10.1371/journal.pmed.0030442 - DOI - PMC - PubMed
    1. Whiteford HA, Degenhardt L, Rehm J, et al. . Global burden of disease attributable to mental and substance use disorders : findings from the Global Burden of Disease Study 2010. Lancet 2013;6736:1–12. - PubMed

Publication types